XPhyto Signs Transformative Acquisition Agreement With 3a-Diagnostics, to Enter Hi-Tech Biosensor Market and Expand Its Diagnostic Product Portfolio
The acquisition creates significant commercial development and manufacturing opportunities for XPhyto as well as cost…
Apptly Announces $1,000,000 Non-Brokered Private Placement
SATO Technologies Corp. Announces Loan Settlement Eliminating All of Its Senior Secured Debt and C$1.5 Million Private Placement
Theralase(R) Closes C$3.6 Million Brokered Financing